| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |